Skip to search formSkip to main contentSkip to account menu

fosaprepitant

Known as: Fosaprepitantum 
National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

AntiemeticsMorpholinesNeurokinin-1 Receptor Antagonists

Narrower (2)

Fosaprepitant dimeglumineL 785,298

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2019
2019
Decitabine and Fosaprepitant Generics Approved by FDA
2018
2018
Abstract P6-11-11: Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting in patients with breast cancer receiving moderately emetogenic chemotherapy regimens
Background: Aprepitant has demonstrated efficacy in patients with breast cancer receiving anthracycline and cyclophosphamide (AC… 
2018
2018
Abstract P6-11-18: Ten year trends in antiemetic prescribing in cancer patients receiving highly emetogenic chemotherapy (HEC)
Purpose: Prevention of chemotherapy-induced nausea and vomiting (CINV) is essential to preserve quality of life in cancer… 
2018
2018
Effect of Antiemetic Agents on Hiccups during Chemotherapy in Patients with Lung Cancer
Hiccups commonly occur in patients undergoing chemotherapy for lung cancer and may diminish their motivation for treatment… 
2016
2016
Novel crystal form of fosaprepitant dual-meglumine compound and preparing method thereof
The invention belongs to the field of medicine, discloses a novel crystal form of a compound for treating nausea and vomiting and… 
2016
2016
Topical Fosaprepitant Treatment in Established Corneal Neovascularization
2014
2014
P3-20-1EFFECTIVENESS OF FOSAPREPITANT, GRANISETRON AND DEXAMETHASONE IN MODERATELY EMETOGENIC CHEMOTHERAPY
Abstract Purpose: There is room for discussion of the optimal method of antiemetic therapy in moderately emetogenic chemotherapy… 
2013
2013
Ef fi cacy and safety of single-dose fosaprepitant in the prevention of chemotherapy-induced nausea and vomiting in patients receiving high-dose cisplatin : a multicentre , randomised , double-blind…
H. Saito1*, H. Yoshizawa2, K. Yoshimori3, N. Katakami4, N. Katsumata5, M. Kawahara6 & K. Eguchi7 Department of Respiratory… 
2013
2013
Method for preparing optically pure fosaprepitant intermediate
The invention discloses a method for preparing a fosaprepitant intermediate (having a structure represented by formula I). The… 
2013
2013
A phase II pilot study of fosaprepitant (F) for the rescue of acute nausea and vomiting with moderately (MEC) or highly emetogenic chemotherapy (HEC) in adults.
e20627^ Background: Patients receiving MEC or HEC continue to have breakthrough nausea and emesis despite antiemetic prophylaxis… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)